News from the NNI Community - Research Advances Funded by Agencies Participating in the NNI

Researchers at the University of Rutgers-New Brunswick have developed a nanotechnology platform that allows researchers to confirm the identity of human stem cell fates and their biomarkers, without destroying these cells in the process. Their discovery could boost research on stem cell transplantation, which may help people with Alzheimer's disease, Parkinson's disease, other neurodegenerative diseases, and central nervous system injuries.

Researchers at NIST have begun to address the issue of variability and accuracy in measuring particle number concentration across several widely used techniques.

Researchers at NIST have begun to address the issue of variability and accuracy in measuring particle number concentration across several widely used techniques.

Engineers at the University of California San Diego have developed a waveguide that is three layers of atoms thin, showing promise to miniaturize optoelectronic devices and to test fundamental physical concepts.

Engineers at the University of California San Diego have developed a waveguide that is three layers of atoms thin, showing promise to miniaturize optoelectronic devices and to test fundamental physical concepts.

Researchers at Rice University have developed biocompatible carbon nanotube fibers that can be used as electrical bridges that span across damaged heart tissue and successfully restore the atrioventricular conduction needed for proper pacing.

Researchers at Rice University have developed biocompatible carbon nanotube fibers that can be used as electrical bridges that span across damaged heart tissue and successfully restore the atrioventricular conduction needed for proper pacing.

A team of researchers from the National Institute of Standards and Technology, the National Institutes of Health, and the University of Maryland have devised a novel, highly sensitive system to track the activity of Cdk5, an enzyme implicated in Alzheimer's disease. The high sensitivity, increased resolution, and fast turnaround time of the measurements can enable a new class of tests that could allow early detection of neurological conditions like Alzheimer’s disease years before the first symptoms appear.

A team of researchers from the National Institute of Standards and Technology, the National Institutes of Health, and the University of Maryland have devised a novel, highly sensitive system to track the activity of Cdk5, an enzyme implicated in Alzheimer's disease. The high sensitivity, increased resolution, and fast turnaround time of the measurements can enable a new class of tests that could allow early detection of neurological conditions like Alzheimer’s disease years before the first symptoms appear.

Researchers at Harvard University have demonstrated genetically programmable self‐regenerating bacterial hydrogels that facilitate wound healing of internal surfaces like those of the gut.